Date Field | Doc. No. | Description (Pages) |
---|
Apr 6, 2017 | 24 | CORRECTED ENTRY: ORDER granting motion to terminate appeal [23] filed by Appellant Merck Sharp & Dohme Corp.; issuing mandate. Service as of this date by Clerk of Court. [422064] --[Edited 04/06/2017 by CB to revise docket text.] [CAB] [Entered: 04/06/2017 01:30 PM] (2) |
Apr 3, 2017 | 23 | MOTION of Appellant Merck Sharp & Dohme Corp. to terminate appeal through Dismissal. [Consent: unopposed]. Service: 04/03/2017 by email. [420938] [Joshua Davis] [Entered: 04/03/2017 01:10 PM] (6) |
Mar 30, 2017 | 20 | ORDER filed. The motion [17] is granted. The confidential and nonconfidential versions of Merck's opening brief are accepted for filing. Teva's response brief is due no later than May 25, 2017. Service: 03/30/2017 by clerk. [420379] [LMS] [Entered: 03/30/2017 03:24 PM] (2) |
Mar 30, 2017 | 21 | CONFIDENTIAL BRIEF FILED for Appellant Merck Sharp & Dohme Corp. [18]. Number of Pages: 51. Service: 03/16/2017 by email. The paper copies of the brief should be received by the court on or before 04/06/2017. [420465] [CAB] [Entered: 03/30/2017 04:31 PM] (0) |
Mar 30, 2017 | 22 | BRIEF FILED for Appellant Merck Sharp & Dohme Corp. [19]. Number of Pages: 51. Service: 03/16/2017 by email. Appellee's response brief is due no later than 05/25/2017. [420470] [CAB] [Entered: 03/30/2017 04:36 PM] (104) |
Mar 16, 2017 | 17 | CORRECTED ENTRY: MOTION of Appellant Merck Sharp & Dohme Corp. to waive confidentiality requirements. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/16/2017 by email. [416212]--[Edited 03/17/2017 by SJ - Reason: to add additional relief] [Nicolas Barzoukas] [Entered: 03/16/2017 01:32 PM] (23) |
Mar 16, 2017 | 18 | TENDERED from Appellant Merck Sharp & Dohme Corp.. Title: CONFIDENTIAL OPENING BRIEF Service: 03/16/2017 by email. [416217] [Nicolas Barzoukas] [Entered: 03/16/2017 01:40 PM] (0) |
Mar 16, 2017 | 19 | TENDERED from Appellant Merck Sharp & Dohme Corp.. Title: OPENING BRIEF. Service: 03/16/2017 by email. [416221] [Nicolas Barzoukas] [Entered: 03/16/2017 01:44 PM] (104) |
Feb 10, 2017 | 16 | **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [14] filed by Appellee Teva Pharmaceuticals USA, Inc. and Appellant Merck Sharp & Dohme Corp. Brief due 03/16/2017.; granting motion to extend time to file appellee's principal brief [14] filed by Appellee Teva Pharmaceuticals USA, Inc. and Appellant Merck Sharp & Dohme Corp. Brief due 05/25/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [406422] [SJ] [Entered: 02/10/2017 11:24 AM] (0) |
Feb 9, 2017 | 15 | Note to file: 17-1560 (COMP COMPANION started 02/09/2017) with 17-1366. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [405989] [17-1366, 17-1560] [JCA] [Entered: 02/09/2017 01:32 PM] (0) |
Feb 6, 2017 | 14 | MOTION of Appellant Merck Sharp & Dohme Corp. and Appellee Teva Pharmaceuticals USA, Inc. to extend the time to 03/16/2017 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service, to extend the time to 05/25/2017 to Assuming Appellant's Brief is filed March 16, 2017 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/06/2017 by email. [405010] [Joshua Davis] [Entered: 02/06/2017 04:17 PM] (10) |
Jan 30, 2017 | 13 | Notice of intent to file corresponding briefs on CD-ROM for Appellant Merck Sharp & Dohme Corp. and Appellee Teva Pharmaceuticals USA, Inc.. Service: 01/30/2017 by email. [403217] [Joshua Davis] [Entered: 01/30/2017 06:23 PM] (3) |
Dec 30, 2016 | 8 | Entry of appearance for Joshua P. Davis as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 12/30/2016 by email. [395439] [Joshua Davis] [Entered: 12/30/2016 03:03 PM] (2) |
Dec 30, 2016 | 9 | Docketing Statement for the Appellant Merck Sharp & Dohme Corp.. Service: 12/30/2016 by email. [395440] [Joshua Davis] [Entered: 12/30/2016 03:05 PM] (3) |
Dec 30, 2016 | 10 | Certificate of Interest for the Appellant Merck Sharp & Dohme Corp.. Service: 12/30/2016 by email. [395441] [Joshua Davis] [Entered: 12/30/2016 03:06 PM] (3) |
Dec 30, 2016 | 11 | Entry of appearance for Lisa M. Thomas as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 12/30/2016 by email. [395442] [Lisa Thomas] [Entered: 12/30/2016 03:10 PM] (2) |
Dec 30, 2016 | 12 | Entry of appearance for Nicolas Barzoukas as principal counsel for Appellant Merck Sharp & Dohme Corp.. Service: 12/30/2016 by email. [395443] [Nicolas Barzoukas] [Entered: 12/30/2016 03:13 PM] (2) |
Dec 21, 2016 | 2 | Entry of appearance for Frederick H. Rein as principal counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/21/2016 by email. [393250] [Frederick Rein] [Entered: 12/21/2016 03:15 PM] (2) |
Dec 21, 2016 | 3 | Certificate of Interest for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/21/2016 by email. [393253] [Frederick Rein] [Entered: 12/21/2016 03:19 PM] (2) |
Dec 21, 2016 | 4 | Docketing Statement for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/21/2016 by email. [393256] [Frederick Rein] [Entered: 12/21/2016 03:22 PM] (3) |
Dec 21, 2016 | 5 | Entry of appearance for Joshua A. Whitehill as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/21/2016 by email. [393262] [Joshua Whitehill] [Entered: 12/21/2016 03:26 PM] (2) |
Dec 21, 2016 | 6 | Entry of appearance for Ira J. Levy as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/21/2016 by email. [393266] [Ira Levy] [Entered: 12/21/2016 03:30 PM] (2) |
Dec 21, 2016 | 7 | Entry of appearance for Michael B. Cottler as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/21/2016 by email. [393268] [Michael Cottler] [Entered: 12/21/2016 03:34 PM] (2) |
Dec 16, 2016 | 1 | Appeal docketed. Received: 12/15/2016. [391739]Entry of Appearance due 12/30/2016. Certificate of Interest is due on 12/30/2016. Docketing Statement due 12/30/2016. Appellant's brief is due 02/14/2017. [AT] [Entered: 12/16/2016 11:01 AM] (27) |